Literature DB >> 17309131

Adipose tissue as a modulator of clinical inflammation: does obesity reduce the prevalence of rheumatoid arthritis?

Tamas Bartfai1, Jill Waalen, Joel N Buxbaum.   

Abstract

OBJECTIVE: Obese individuals display circulating proinflammatory cytokine elevations similar to those in patients with rheumatoid arthritis (RA). We wished to determine if extremely obese individuals were overrepresented among a group of patients with RA.
METHODS: We performed both multi- and univariate analyses of data from a large, community-based population attending the "wellness" clinic of a large health maintenance organization in Southern California. We also examined the data from 5 other studies that examined the relationship between various environmental factors and the incidence and prevalence of RA.
RESULTS: We found no relationship between the prevalence of RA and body mass index (BMI) in our own data or in the preponderance of previously published studies examining the same question.
CONCLUSION: Although both RA and obesity have been reported to be characterized by high serum levels of inflammatory cytokines, the frequency of one disorder was not increased in the other. We propose that the lack of association in prevalence between the 2 inflammatory states, rather than reflecting a post-hoc effect of the disease on BMI, is a function of the relative amounts of pro- and antiinflammatory mediators produced in adipose tissue, which under many circumstances leads to an overall systemic antiinflammatory tone.

Entities:  

Mesh:

Year:  2007        PMID: 17309131

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

1.  Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) Family Study: rationale and design for a randomized controlled trial evaluating rheumatoid arthritis risk education to first-degree relatives.

Authors:  Jeffrey A Sparks; Maura D Iversen; Rachel Miller Kroouze; Taysir G Mahmoud; Nellie A Triedman; Sarah S Kalia; Michael L Atkinson; Bing Lu; Kevin D Deane; Karen H Costenbader; Robert C Green; Elizabeth W Karlson
Journal:  Contemp Clin Trials       Date:  2014-08-20       Impact factor: 2.226

2.  Computational deconvolution of synovial tissue cellular composition: presence of adipocytes in synovial tissue decreased during arthritis pathogenesis and progression.

Authors:  Wenhui Wang; Li Wang; Percio S Gulko; Jun Zhu
Journal:  Physiol Genomics       Date:  2019-05-17       Impact factor: 3.107

3.  Effect of feeding status on adjuvant arthritis severity, cachexia, and insulin sensitivity in male Lewis rats.

Authors:  Andrea Stofkova; Blanka Zelezna; Marianna Romzova; Olga Ulicna; Alexander Kiss; Martina Skurlova; Jana Jurcovicova
Journal:  Mediators Inflamm       Date:  2010-09-30       Impact factor: 4.711

Review 4.  Metabolic syndrome in rheumatoid arthritis.

Authors:  Iván Ferraz-Amaro; Carlos González-Juanatey; Raquel López-Mejias; Leyre Riancho-Zarrabeitia; Miguel A González-Gay
Journal:  Mediators Inflamm       Date:  2013-01-30       Impact factor: 4.711

5.  Impact of the Uncoupling Protein 1 on Cardiovascular Risk in Patients with Rheumatoid Arthritis.

Authors:  Lovisa I Lyngfelt; Malin C Erlandsson; Mitra Nadali; Shahram Hedjazifar; Rille Pullerits; Karin M Andersson; Petra Brembeck; Sofia Töyrä Silfverswärd; Ulf Smith; Maria I Bokarewa
Journal:  Cells       Date:  2021-05-07       Impact factor: 6.600

6.  Response to: 'Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis'--authors' reply.

Authors:  Baodong Qin; Yan Liang; Zaixing Yang; Renqian Zhong
Journal:  Arthritis Res Ther       Date:  2015-08-19       Impact factor: 5.156

7.  Response to 'Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis'.

Authors:  Yang Liu; Cheryl Barnabe
Journal:  Arthritis Res Ther       Date:  2015-08-19       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.